SOPH SOPHiA GENETICS, Inc.
SOPHiA GENETICS, Inc. (SOPH) is expected to report earnings on November 3, 2026, before the market open. The consensus earnings estimate is a loss of $0.13 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +24.0% since its last earnings release on August 4, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About SOPHiA GENETICS, Inc.
SOPHiA GENETICS is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research.
Sector
Healthcare
Industry
Healthcare Info Services